Item 8.01 Other Events.
On January 13, 2021, the Company entered into an agreement whereby independent
of the Company's wholly-owned subsidiary, ABV Consulting Limited will agree to
market and sell the Company's core product, a health-oriented specialty rice.
In consideration for agreeing to market and sell the Company's product, the
Company will agree to issue up to 5,000,000 shares of common stock. The
independent contractors will receive stock at a rate of fifty percent (50%) of
the sales price of the rice. The shares will be issued at the greater of $1.50
per shares, or the then current price of the common stock as traded on the
OTCMarkets.
The shares will be issued pursuant to Section 4(2(a) of the Securities Act of
1933, and Regulation S promulgated thereunder.
In addition, the Company will be entering into an agreement with Xinjiang Hefeng
Zhitong Biotechnology Co., Ltd., to assist in the distribution of rice and the
supervision of the independent contractors.
2
© Edgar Online, source Glimpses
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
